- General info
- Available languages
- Background story
LFT Etica™ font family
Designed by Leftloft
Up to 40 Typefaces / 2 Value Packs
Supports at least 33 languages (Pro / OT CFF)
Available licenses for all styles:
Supports up to 74 languages.
Please select a format to view the available languages:
Supports up to 23 OpenType features.
Please select a format to view the available OpenType features:
Etica, the-moralist-typefamily-project, was born at the end of 2000, but its development is ongoing, overcoming many hurdles and diversions. On one hand, the original idea was spurred by a certain esteem for Helvetica, in particular, its strength and versatility, and on the other, an intolerance to its plenty but inadequate applications; created by those who erroneously consider it to be a neutral and timeless design. We believe that Helvetica is a beautiful typeface, but very deeply rooted in its own era. It is often unsuitably used in contexts that have changed profoundly since its birth. From this initial intention, we coined the ironic payoff "The-Moralist-Typeface". The challenge was to obtain the same force, versatility and colour that are, from our point of view, Helvetica's greatest qualities. The same proportions have been maintained, albeit with slightly reduced letter width. The resulting design has soft strokes, open counters and terminals; aesthetically resting somewhere between a grotesque and humanist sans serif. It successfully combines masculine force with female delicacy. Etica's wide range of styles, together with a large character set and OpenType features, such as 4 sets of numerals, fractions, several stylistic alternates and a set of arrows and dingbats, allows for a vast variety of applications, be they editorial or corporate.
Download a free trial
Use this font in your own documents with a free 5 minute trial through SkyFonts. Trials are for evaluation purposes only. Learn more.
This font is currently not available.
You already tried this font within the last 24 hours or you may have exceeded your daily allowance of trials. Learn more.